Versor Investments LP Boosts Stake in Integer Holdings Corporation $ITGR

Versor Investments LP raised its holdings in shares of Integer Holdings Corporation (NYSE:ITGR) by 48.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,404 shares of the medical equipment provider’s stock after buying an additional 1,113 shares during the quarter. Versor Investments LP’s holdings in Integer were worth $402,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. AdvisorNet Financial Inc purchased a new position in Integer during the first quarter worth about $28,000. Opal Wealth Advisors LLC purchased a new position in shares of Integer in the 1st quarter worth about $28,000. Bessemer Group Inc. boosted its holdings in shares of Integer by 73.1% in the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider’s stock worth $35,000 after purchasing an additional 125 shares in the last quarter. Sterling Capital Management LLC boosted its holdings in shares of Integer by 472.9% in the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider’s stock worth $45,000 after purchasing an additional 279 shares in the last quarter. Finally, Headlands Technologies LLC boosted its holdings in shares of Integer by 1,234.8% in the 1st quarter. Headlands Technologies LLC now owns 1,228 shares of the medical equipment provider’s stock worth $145,000 after purchasing an additional 1,136 shares in the last quarter. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Integer Stock Up 0.8%

Shares of NYSE:ITGR opened at $107.1720 on Thursday. Integer Holdings Corporation has a 52-week low of $104.93 and a 52-week high of $146.36. The firm has a market capitalization of $3.75 billion, a P/E ratio of 47.21, a P/E/G ratio of 0.84 and a beta of 1.02. The stock has a 50 day moving average price of $114.15 and a 200-day moving average price of $119.62. The company has a debt-to-equity ratio of 0.72, a quick ratio of 2.18 and a current ratio of 3.41.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.02). Integer had a return on equity of 12.27% and a net margin of 4.61%.The firm had revenue of $476.00 million during the quarter, compared to the consensus estimate of $464.37 million. During the same period in the prior year, the company posted $1.30 EPS. The firm’s revenue was up 11.4% on a year-over-year basis. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. As a group, equities research analysts anticipate that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.

Insider Buying and Selling

In other Integer news, Director Martin C. Maxwell sold 8,720 shares of the stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the sale, the director directly owned 22,170 shares in the company, valued at approximately $2,672,815.20. This trade represents a 28.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Donald J. Spence sold 14,739 shares of the stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total value of $1,774,280.82. Following the sale, the director owned 18,781 shares in the company, valued at approximately $2,260,856.78. This represents a 43.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.16% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

ITGR has been the subject of a number of research reports. Citigroup upgraded Integer from a “hold” rating to a “strong-buy” rating and upped their price objective for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. Truist Financial decreased their price target on Integer from $145.00 to $137.00 and set a “buy” rating on the stock in a research note on Friday, July 25th. Wall Street Zen raised Integer from a “sell” rating to a “hold” rating in a research note on Monday, May 19th. Wells Fargo & Company decreased their price target on Integer from $152.00 to $132.00 and set an “overweight” rating on the stock in a research note on Friday, July 25th. Finally, Benchmark decreased their price target on Integer from $150.00 to $140.00 and set a “buy” rating on the stock in a research note on Friday, April 25th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $140.25.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.